π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
To investigate the efficacy and safety of three different doses of ASP2151,...
Status
Completed
Location
Multiple Locations
Start Date
2007-11-13
Trial ID
NCT00487682
Treatments Being Tested
To evaluate the efficacy and safety of ASP2151 (200 mg and 400 mg) in compa...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01959841
Treatments Being Tested
To evaluate the efficacy and safety of ASP2151 in patients with herpes simp...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01959295
Treatments Being Tested
ASP2151 is an experimental treatment for herpes. HIV infected people are su...
Status
Completed
Location
Hammersmith Medicines Research Ltd
Start Date
2014-09
Trial ID
NCT02223351
CYP3A4 is involved in the metabolism of many drugs. So, it is important to ...
Status
Completed
Location
Hammersmith Medicines Research Ltd
Start Date
2015-04
Trial ID
NCT02403635
CYP2C8 is involved in the metabolism of many drugs. So, it is important to ...
Status
Completed
Location
Hammersmith Medicines Research Ltd
Start Date
2014-12
Trial ID
NCT02321748
Treatments Being Tested
ASP2151 is an experimental treatment for herpes. Patients undergoing organ ...
Status
Completed
Location
Hammersmith Medicines Research Ltd
Start Date
2014-10
Trial ID
NCT02280421
Treatments Being Tested
The objective of this study is to evaluate the safety and tolerability of s...
Status
Completed
Location
Site FR1717
Start Date
2005-09
Trial ID
NCT02852876
The objective of this study is to evaluate the safety and the pharmacokinet...
Status
Completed
Location
Site JP00001
Start Date
2006-07
Trial ID
NCT02796118
A study of ASP2151 in subjects with recurrent outbreaks of genital herpes....
Status
Completed
Location
Multiple Locations
Start Date
2007-06-21
Trial ID
NCT00486200
Treatments Being Tested